Sanjivani launches new drug for viral diseases
Pharmaceutical firm Sanjivani Paranteral on Friday said it has developed a new product for the treatment of contagious viral diseases, such as Bird Flu.
MUMBAI: Pharmaceutical firm Sanjivani Paranteral on Friday said it has developed a new product for the treatment of contagious viral diseases, such as Bird Flu.
Apart from Bird flu the company's new product, Sancidal, can also be used in the treatment of other viruses such as Lassa Fever, HIV Virus, Hepatitis B and Yellow Fever, Sanjivani informed the Bombay Stock Exchange.
The product has a global market of $3 billion. It has been commercially launched in the domestic market and the company is in talks with various international players to launch the drug globally, it said.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.